Funder
NIH
Northwestern University Feinberg School of Medicine
Reference50 articles.
1. Trends in kinase drug discovery: targets, indications and inhibitor design;Attwood;Nat. Rev. Drug Discov.,2021
2. Pharmacology of modulators of alternative splicing;Bates;Pharmacol. Rev.,2017
3. Roles and mechanisms of alternative splicing in cancer - implications for care;Bonnal;Nat. Rev. Clin. Oncol.,2020
4. Abstract 5691: SM08502, a novel, small-molecule CDC-like kinase (CLK) inhibitor, demonstrates strong antitumor effects and Wnt pathway inhibition in castration-resistant prostate cancer (CRPC) models;Bossard;Cancer Res.,2020
5. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells;Bowler;BMC Cancer,2018